FDA Adverse Event
Malfunction
Summary report: N
VERSA
MDR report key: 19998701
·
Received August 15, 2024
Report
- Report Number
- MW5158528
- Event Type
- Malfunction
- Date Received
- August 15, 2024
- Report Date
- August 13, 2024
- Manufacturer
- PROLLENIUM MEDICAL TECHNOLOGIES INC.
- Product Code
- LMH
- Product Problem
- Yes
- Report Source
- Voluntary report
- Reporter Occupation
- OTHER
- Health Professional
- *
Narratives
Description of Event or Problem · 0
PROLLENIUM IS INCENTIVIZING REPS TO SELL ITS PRODUCT VERSA FOR OFF-LABEL INDICATION. SOME REPS, INCLUDING THE GM ARE GETTING MONETARY INCENTIVE - COMMISSION AND OR BONUS FOR SELLING OFF LABEL TO PHALOFIL. PHALLOFIL EXCLUSIVELY PERFORMS PENILE ENHANCEMENT AND PROLLENIUM SELLS HEAVILY TO THEM. THE PROBLEM IS THAT REPS AND GM ARE MAKING A SIGNIFICANT AMOUNT OF COMMISSION KNOWING THAT THIS IS OFF LABEL. EMPLOYEES WHO REPORTED THIS TO MANAGEMENT WERE FIRED. ASK TO SAY THE COMMISSION REPORTS AND BACK UP DATA FOR (B)(4).
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1619998 | VERSA | IMPLANT, DERMAL, FOR AESTHETIC USE | LMH | PROLLENIUM MEDICAL TECHNOLOGIES INC. |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | NA | Unknown | Other |